ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 782 out of 4623

$427K Total Retail Price of All Prescriptions

Rank: 984 out of 4623

316 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

30% of this provider’s 316 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 6,294 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 512 315 S3 1 3
MELOXICAM 291 236 2 27
FUROSEMIDE 279 223 3 8
LISINOPRIL 231 195 4 4
OMEPRAZOLE 216 148 5 7
PRAVASTATIN SODIUM 210 157 6 11
AMLODIPINE BESYLATE 209 185 7 5
SIMVASTATIN 200 183 8 2
METFORMIN HCL 190 154 9 6
LEVOTHYROXINE SODIUM 179 139 10 1
POTASSIUM CHLORIDE 149 117 11 14
GLIMEPIRIDE 144 116 12 38
CITALOPRAM HBR 134 104 13 23
METOPROLOL TARTRATE 134 111 13 9
AMLODIPINE BESYLATE-BENAZEPRIL 111 80 15 55
CARVEDILOL 111 84 15 25
ZOLPIDEM TARTRATE 108 36 17 18
ATORVASTATIN CALCIUM 98 73 18 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 68 19 19
WARFARIN SODIUM 87 71 20 24
DILTIAZEM 24HR CD 84 73 21 156
METOPROLOL SUCCINATE 81 45 22 13
CLONIDINE HCL 77 65 23 40
KLOR-CON M10 77 76 23 137
TRAMADOL HCL 76 41 25 15
ALENDRONATE SODIUM 75 74 26 22
AMITRIPTYLINE HCL 71 44 R 27 69
SERTRALINE HCL 70 54 28 26
LYRICA 70 34 28 66
HYDROCHLOROTHIAZIDE 69 62 30 10
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 46 31 146
SPIRIVA 67 49 31 79
JANUVIA 62 61 33 52
CYCLOBENZAPRINE HCL 60 27 R 34 53
TAMSULOSIN HCL 60 46 34 29
TRAZODONE HCL 59 50 36 42
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 48 37 68
RAMIPRIL 57 40 38 76
TRILIPIX 56 35 39 150
CLOPIDOGREL 56 49 39 31
DIGOXIN 55 36 41 58
NEXIUM 54 37 42 17
PLAVIX 54 50 42 45
TRIMETHOPRIM 53 53 44 421
CRESTOR 52 31 45 20
KLOR-CON M20 51 38 46 102
FLUTICASONE PROPIONATE 50 28 47 32
PREDNISONE 50 35 47 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.